Skip to main content

 

FDA’s 510(k) Recommendations

By Commentary No Comments

The FDA’s 510(k) medical device approval process has been criticized for requiring too little data on potentially harmful devices. The FDA undertook a review of the process and has issued a description of initial steps it plans to take, which the industry seems to view as acceptable.

Read More

2011 Potpourri VI

By Commentary No Comments

Our usual end-of-the-week collection of health care tidbits, featuring HIE vendor awards; the point-of-care testing market; what makes medical groups successful; family caregivers and technology; clinical decision software for imaging; health care employee compensation; and communication between primary care and specialist physicians.

Read More

Genomics and the DOD

By Commentary No Comments

Personalized medicine has taken somewhat of a back burner in the wake of reform, but the science continues to evolve. An interesting report looks at how the Department of Defense might be able to use genetic information, particularly as it becomes much less expensive to acquire.

Read More

2011 Potpourri V

By Commentary No Comments

On we go, wading through piles of research to arm you with the most relevant snatches of data, this week featuring geographic variation in the quality of drug prescribing; use of Facebook communities for health purposes; physicians’ hourly wages; medication adherence programs; surgical safety improvement; and using survey data to assess patient satisfaction.

Read More

Spreading Medical Knowledge

By Commentary No Comments

An article in Health Affairs discusses the important topic of disseminating new medical and health care knowledge to physicians and other providers, in this case specifically in regard to comparative effectiveness. Many barriers exist to widespread use of new knowledge and additional techniques are needed to maximize such use.

Read More